04 August 2023
04 August 2023
For nine months that ended on 30 June 2023, the company posted total revenues of $14.2bn as against $14.1bn in the prior year.
In March this year, the company received FDA EUA for the Cue Mpox Molecular Test.
The expanded indication enables the use of the system to treat critically ill patients diagnosed with AKI who need dialysis.
The company plans to track patients from the WAVE study for 24 months.
As the US Solicitor General takes aim at the Sacklers, another infamous pharma head is back with a new project.
In the latest Brexit step-down, many goods will now have indefinite CE mark recognition – but MHRA keeps 2028 and 2030 cut-offs for medical devices.
A drug-coated balloon that helps restore blood vessels via light activation has been approved for use in US clinical trials, following an investigational device exemption (IDE) by the US Food and Drug Administration (FDA).
As renal denervation approaches a landmark FDA hearing, will it become a go-to treatment option or a forgotten novelty?
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
